ApoA-I mimetics: Tomatoes to the rescue

Journal of Lipid Research

Volumn 54, Issue 4, 2013, Pages 878-880

  Getz, Godfrey S ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; AMINO ACID; APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; DEXTRO AMINO ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; PEPTIDOMIMETIC AGENT; PHENYLALANINE; PHOSPHOLIPASE D; SERUM AMYLOID A; TRIACYLGLYCEROL; TRYPSIN;

ACYLATION; AMIDATION; AMINO TERMINAL SEQUENCE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL BLOOD LEVEL; DIGESTION; DISEASE MODEL; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG STABILITY; DRUG STRUCTURE; HYPERLIPIDEMIA; INFLAMMATORY DISEASE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHIZOBIUM RADIOBACTER; TOMATO; TRANSGENIC PLANT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN A-I; FEMALE; PEPTIDES;

EID: 84875851489     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E037572     Document Type: Note

References (9)

1. Chattopadhyay, A., M. Navab, G. Hough, G. Gao, D. Meriwether, V. Grijalva, J. R. Springstead, M. N. Palgnachari, R. Namiri-Kalantari, F. Su, et al. 2013. A novel approach to oral apoA-I mimetic therapy. J. Lipid Res. 54 : 995-1010.
2. Van Lenten, B. J., M. Navab, G. M. Anantharamaiah, G. M. Buga, S. T. Reddy, and A. M. Fogelman. 2008. Multiple indications for anti-infl ammatory apolipoproteins mimetic peptides. Curr. Opin. Investig. Drugs. 9 : 1157-1162.
3. Getz, G. S., and C. A. Reardon. 2011. Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. J Infl amm. Res. 4 : 83-92.
4. Anantharamaiah, G. M., J. L. Jones, C. G. Brouillette, C. F. Schmidt, B. H. Chung, T. A. Hughes, A. S. Bhown, and J. P. Segrest. 1985. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidycholine. J. Biol. Chem. 260 : 10248-10255.
5. Datta, G., M. Chaddha, S. Hama, M. Navab, A. M. Fogelman, D. W. Garber, V. K. Mishra, R. M. Epand, R. F. Epand, S. Lund-Katz, et al. 2001. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J. Lipid Res. 42 : 1096-1104.
6. Navab, M., S. T. Reddy, B. J. Van Lenten, G. M. Buga, G. Hough, A. C. Wagner, and A. M. Fogelman. 2012. High-density lipoprotein and 4F peptide reduce systemic infl ammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. Arterioscler. Thromb. Vasc. Biol. 32 : 2553-2560.
7. Gelvin, S. B. 2003. Agrobacterium-mediated plant transformation: the biology behind the "gene-jockeying" tool. Microbiol. Mol. Biol. Rev. 67 : 16-37.
8. Van Lenten, B. J., A. C. Wagner, C. L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah, et al. 2008. Anti-infl ammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affi nity than human apoA-I. J. Lipid Res. 49 : 2302-2311.
9. Chiba, T., M. Y. Chang, S. Wang, T. N. Wight, T. S. McMillen, J. F. Oram, T. Vaisar, J. W. Heinecke, F. C. De Beer, M. C. De Beer, et al. 2011. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler. Thromb. Vasc. Biol. 31 : 1326-1332.